Social isolation linked to dementia in national study
By
Alicia Lasek
Jan 11, 2023
Nearly one in four older adults in the United States are socially isolated, and at higher risk for developing dementia over the next decade, according to new findings.
Preventable diseases tied to common, age-related eye condition, study finds
By
Alicia Lasek
Jan 11, 2023
Age-related macular degeneration is linked to two potentially treatable diseases, suggesting new pathways for preventing progression and blindness, investigators say.
Latest COVID shot cuts hospitalizations in seniors by 81 percent: study
By
Alicia Lasek
Jan 10, 2023
Seniors who receive an omicron-adapted shot are 81% less likely to be hospitalized with severe COVID-19, according to a new study from Israel.
With education and a doc’s OK, most seniors agree to deprescribe unneeded meds: study
By
Alicia Lasek
Jan 10, 2023
Seniors are willing to take their doctor’s advice to discontinue an unneeded medication after viewing an educational video, investigators say.
FDA approves new drug Leqembi to treat early Alzheimer’s disease
By
Alicia Lasek
Jan 09, 2023
The newly approved drug Leqembi (lecanemab) may slow progression of cognitive decline due to Alzheimer’s disease, trial data show. CMS says it may rethink Medicare coverage of drugs in Leqembi’s...
Senior care association opens free COVID test kit program to all providers
By
Alicia Lasek
Jan 09, 2023
Industry advocate LeadingAge is now offering free test kits to long-term care providers in all care settings and communities.
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.
Peer messaging tool tackles workplace behavior, shows success in nurse study
By
Alicia Lasek
Jan 06, 2023
The CORS tool allows behavior to be anonymously reported and addressed by a trained peer, without involving nursing leadership or human resources unless necessary.
Vascular risk factors raise odds of Alzheimer’s disease in Blacks, Hispanics: study
By
Alicia Lasek
Jan 05, 2023
Vascular risk helps to explain the outsized odds of Alzheimer’s faced by African Americans and Hispanics in the United States, a new study has found.
On eve of Alzheimer’s drug decision, Congress critiques FDA for Aduhelm review failures
By
Alicia Lasek
Jan 03, 2023
An “atypical review process and corporate greed” factored into the FDA’s approval of Alzheimer’s drug Aduhelm in 2021, congressional investigators say. They recommend sticking to protocol...